QS Investors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$316,000
+4.3%
3,1750.0%0.00%0.0%
Q3 2020$303,000
-79.7%
3,175
-76.2%
0.00%
-81.0%
Q2 2020$1,495,000
+53.8%
13,3650.0%0.02%
+40.0%
Q1 2020$972,000
-30.2%
13,365
+0.6%
0.02%
+7.1%
Q4 2019$1,392,000
+4.4%
13,290
-0.7%
0.01%
-6.7%
Q3 2019$1,333,000
-12.8%
13,3900.0%0.02%
-6.2%
Q2 2019$1,529,000
-11.3%
13,390
-2.3%
0.02%
-15.8%
Q1 2019$1,724,000
+2398.6%
13,710
+2625.6%
0.02%
+1800.0%
Q4 2018$69,000
-50.0%
5030.0%0.00%0.0%
Q3 2018$138,000
+32.7%
5030.0%0.00%0.0%
Q2 2018$104,000
+25.3%
5030.0%0.00%0.0%
Q1 2018$83,000
+20.3%
5030.0%0.00%0.0%
Q4 2017$69,000
+1.5%
5030.0%0.00%0.0%
Q3 2017$68,000
+11.5%
5030.0%0.00%0.0%
Q2 2017$61,000
+15.1%
5030.0%0.00%
Q1 2017$53,000
+5200.0%
503
+16666.7%
0.00%
Q4 2016$1,0000.0%30.0%0.00%
Q3 2016$1,0000.0%3
+50.0%
0.00%
Q2 2016$1,0000.0%2
-60.0%
0.00%
Q1 2016$1,0000.0%5
+150.0%
0.00%
Q4 2015$1,00020.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders